Over 30,000 people develop tuberculosis in Peru every year, including about 4,700 children. Peru’s public health facilities for multi-drug-resistant and extensively drug-resistant TB are becoming increasingly overburdened, and there are no private clinics which offer the necessary infrastructure and security to provide care. To support the ongoing battle against drug-resistant tuberculosis and other serious infectious diseases, BHI is partnering with Socios en Salud in Peru and the Quincy, MA architectural firm, Studio Umbra, to advise on and design a three-story diagnostic and treatment complex on the northern outskirts of Lima, Peru.

In addition to including outpatient and inpatient services for those fighting tuberculosis, the center will also feature a research center and BSL-3 laboratory, which will allow for the diagnosis of diseases such as HIV, hepatitis, meningitis, cholera, Zika, and chikungunya.

“The idea is to make this great complex where we can provide the best standard of care using all of our combined experience,” says Dr. Leonid Lecca, a renowned tuberculosis expert and executive director of Socios En Salud...."We can then say to the world, ‘Here, all TB patients are cured. Here no patient abandons treatment.’”